Company Encyclopedia
View More
name
Niagen Bioscience
NAGE.US
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products.
766.24 B
NAGE.USMarket value -Rank by Market Cap -/-

Financial Score

07/12/2025 Update
A
Life Sciences Tools and ServicesIndustry
Industry Ranking1/61
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE38.90%A
    • Profit Margin16.38%A
    • Gross Margin64.52%A
  • Growth ScoreA
    • Revenue YoY36.04%A
    • Net Profit YoY1275.69%A
    • Total Assets YoY73.63%A
    • Net Assets YoY105.64%A
  • Cash ScoreB
    • Cash Flow Margin610.45%C
    • OCF YoY36.04%A
  • Operating ScoreA
    • Turnover1.61A
  • Debt ScoreB
    • Gearing Ratio27.98%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More